Trial intelligence / Profile preview

ASAQ Winthrop Effectiveness in Uncomplicated Malaria

NCT01023399Phase 4Completed

Sponsor
Sanofi
Start
Nov 2009
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of artesunate + amodiaquine in Plasmodium falciparum malaria, sponsored by Sanofi. Started Nov 2009; status: completed.

02

Drugs

artesunate + amodiaquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT01023399.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01023399.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call